Tag: #Global Trends

Sarepta Therapeutics saw its stock jump 25% on Wednesday, March 25, 2026, following the release of encouraging Phase 1/2 clinical... Read more

On March 23, 2026, Gilead Sciences announced a definitive agreement to acquire Ouro Medicines in a deal potentially worth $2.175... Read more

On March 24, 2026, Bayer’s stock experienced a brief decline following a significant divestment by Inclusive Capital Partners. The move... Read more

On March 25, 2026, Japan’s largest pharmaceutical company, Takeda, unveiled a sweeping new restructuring initiative. The program aims to deliver... Read more

On March 25, 2026, during the company’s 2025 earnings presentation, Boehringer Ingelheim Chairman Shashank Deshpande touted robust financial results but... Read more

Pfizer and Valneva have announced their intention to proceed with regulatory filings for their Lyme disease vaccine candidate (PF-07307405/VLA15), even... Read more

French pharmaceutical giant Sanofi entered into a strategic licensing agreement with California-based Kali Therapeutics to secure exclusive worldwide rights to... Read more

On March 23, 2026, global healthcare company Viatris Inc. announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has... Read more

On March 23, 2026, Just – Evotec Biologics announced its selection by the U.S. Biomedical Advanced Research and Development Authority... Read more